{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:37:19Z","timestamp":1762079839286},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T00:00:00Z","timestamp":1647561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T00:00:00Z","timestamp":1647561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>To establish content validity of a single-item, migraine-specific symptom severity questionnaire for completion by migraine patients, key family members (KFMs) of migraine patients, and Healthcare Professionals (HCPs) who treat migraine patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Migraine is a common disabling primary headache disorder with high prevalence and significant socioeconomic burden and personal impacts. There is a need for a global assessment of migraine symptom severity to evaluate potential new therapies from multiple perspectives.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The migraine Global Impression Item (mGI-I) was drafted and tested in a non-interventional, qualitative study comprising telephone interviews with 15 migraine patients, 15 KFMs of migraine patients, and 15 migraine treating HCPs. The mGI-I was drafted with two different item stem options and two different response scale options to ask about the patient\u2019s migraine from the perspective of each respondent. Cognitive interviews were conducted to test comprehensiveness, clarity and ease of completion of the different versions of the mGI-I iteratively in three sequential waves of respondents.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Revisions were made to the draft mGI-I after Wave 1 and Wave 2 of the interviews. Changes were made to simplify the item stem (removing unnecessary text), make language more patient-friendly (e.g. use of \u201cmigraine attack\u201d), and add clarity to the item stem for consistent interpretation (include descriptive language of migraine attacks). Across both waves there was a preference for a 5-point response scale compared to a 7-point scale. In Wave 3, all respondents found the revised instructions, item stem, and 5-point response scale comprehensive, easy to understand and to answer. No further changes to the mGI-I were made after Wave 3.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This qualitative study of 45 total respondents across 3 subpopulations, established the content validity and appropriateness of the mGI-I in migraine patients, KFMs, and migraine-treating HCPs. The study specifically confirmed that the mGI-I is comprehensive, easily understood and answered for each respondent population.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12883-022-02626-0","type":"journal-article","created":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T09:03:42Z","timestamp":1647594222000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Establishing content validity for the migraine Global Impression Item (mGI-I) assessment: a modified single-item migraine symptom severity questionnaire"],"prefix":"10.1186","volume":"22","author":[{"given":"David","family":"Chandler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Navetta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shweta","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Cline","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Phinney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,18]]},"reference":[{"issue":"6","key":"2626_CR1","doi-asserted-by":"publisher","first-page":"e00950","DOI":"10.1002\/brb3.950","volume":"8","author":"WZ Yeh","year":"2018","unstructured":"Yeh WZ, Blizzard L, Taylor BV. What is the actual prevalence of migraine? Brain Behav. 2018;8(6):e00950. https:\/\/doi.org\/10.1002\/brb3.950https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5991594\/.","journal-title":"Brain Behav"},{"issue":"4","key":"2626_CR2","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1111\/head.13281","volume":"58","author":"R Burch","year":"2018","unstructured":"Burch R, Rizzoli P, Loder E. The prevalence and impact of migraine and severe headache in the United States: figures and trends from government health studies. Headache. 2018 Apr;58(4):496\u2013505. https:\/\/doi.org\/10.1111\/head.13281 Epub 2018 Mar 12. PMID: 29527677. https:\/\/pubmed.ncbi.nlm.nih.gov\/29527677\/.","journal-title":"Headache."},{"issue":"1","key":"2626_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/0333102417738202","volume":"38","author":"Headache Classification Committee of the International Headache Society (IHS)","year":"2018","unstructured":"Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38(1):1\u2013211. https:\/\/doi.org\/10.1177\/0333102417738202 PMID: 29368949. https:\/\/ichd-3.org.","journal-title":"Cephalalgia"},{"key":"2626_CR4","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/S0140-6736(16)31678-6","volume":"388","author":"T Vos","year":"2016","unstructured":"Vos T, Allen C, Arora M, Barber RM, Bhutta ZA, Brown A, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990\u20132015: a systematic analysis for the global burden of disease study 2015. Lancet. 2016;388:1545\u2013602. http:\/\/www.thelancet.com\/retrieve\/pii\/S0140673616316786.","journal-title":"Lancet"},{"key":"2626_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s10194-018-0846-2","volume":"19","author":"TJ Steiner","year":"2018","unstructured":"Steiner TJ, Sovner LJ, Vos T, Jensen R, Katsarava Z. Migraine is first cause of disability in under 50s: will health politicians now take notice? J Headache Pain. 2018;19:17. https:\/\/thejournalofheadacheandpain.biomedcentral.com\/articles\/10.1186\/s10194-018-0846-2.","journal-title":"J Headache Pain"},{"issue":"0","key":"2626_CR6","first-page":"1","volume":"0","author":"AM Adams","year":"2014","unstructured":"Adams AM, Serrano D, Buse DC, Reed ML, Marske V, Fanning KM, et al. The impact of chronic migraine: the chronic migraine epidemiology and outcomes (CaMEO) study methods and baseline results. Int Headache Soc Cephalalgia. 2014;0(0):1\u201316.","journal-title":"Int Headache Soc Cephalalgia"},{"key":"2626_CR7","doi-asserted-by":"crossref","unstructured":"Sajobi TT, Amoozegar F, Wang M, et al. Global assessment of migraine severity measure: preliminary evidence of construct validity. BMC Neurol. 2019;19(1). NA. Gale Academic OneFile. Accessed 12 Mar\u00a02021. https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-019-1284-8.","DOI":"10.1186\/s12883-019-1284-8"},{"key":"2626_CR8","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s10194-018-0907-6","volume":"19","author":"P Vo","year":"2018","unstructured":"Vo P, Fang J, Bilitou A, Laflamme A, Gupta S. Patients\u2019 perspective on the burden of migraine in Europe: a cross-sectional analysis of survey data in France, Germany, Italy, Spain, and the United Kingdom. J Headache Pain. 2018;19:82.","journal-title":"J Headache Pain"},{"key":"2626_CR9","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s10194-018-0946-z","volume":"19","author":"P Martelletti","year":"2018","unstructured":"Martelletti P, Schwedt TJ, Lanteri-Minet M, et al. My migraine voice survey: a global study of disease burden among individuals with migraine for whom preventive treatments have failed. J Headache Pain. 2018;19:115. https:\/\/doi.org\/10.1186\/s10194-018-0946-zhttps:\/\/thejournalofheadacheandpain.biomedcentral.com\/articles\/10.1186\/s10194-018-0946-z.","journal-title":"J Headache Pain"},{"issue":"Suppl 1","key":"2626_CR10","doi-asserted-by":"publisher","first-page":"s21","DOI":"10.1007\/s101940170004","volume":"2","author":"G Apolone","year":"2001","unstructured":"Apolone G, Mosconi P. Health-related quality of life (HRQOL) and migraine. J Headache Pain. 2001;2(Suppl 1):s21\u20134. https:\/\/link.springer.com\/content\/pdf\/10.1007%252Fs101940170004.pdf.","journal-title":"J Headache Pain"},{"key":"2626_CR11","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1023\/A:1026119331193","volume":"12","author":"M Kosinski","year":"2003","unstructured":"Kosinski M, Bayliss MS, Bjorner JB, Ware JE, Garber WH, Batenhorst A, et al. A six-item short-form survey for measuring headache impact: the HIT-6. Qual Life Res. 2003;12:963\u201374. https:\/\/link.springer.com\/article\/10.1023%2FA%3A1026119331193.","journal-title":"Qual Life Res"},{"key":"2626_CR12","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1212\/WNL.44.5.837","volume":"44","author":"GP Jacobson","year":"1994","unstructured":"Jacobson GP, Ramadan NM, Aggarwal SK, Newman CW. The Henry ford hospital headache disability inventory (HDI). Neurology. 1994;44:837. https:\/\/n.neurology.org\/content\/44\/5\/837.","journal-title":"Neurology."},{"key":"2626_CR13","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1046\/j.1526-4610.2003.03105.x","volume":"43","author":"A El Hasnaoui","year":"2003","unstructured":"El Hasnaoui A, Vray M, Richard A, Nachit-Ouinekh F, Boureau F, MIGSEV Group. Assessing the severity of migraine: development of the MIGSEV scale. Headache. 2003;43:628\u201335. https:\/\/doi.org\/10.1046\/j.1526-4610.2003.03105.x.","journal-title":"Headache."},{"key":"2626_CR14","first-page":"218","volume-title":"ECDEU Assessment Manual for Psychopharmacology-Revised","author":"W Guy","year":"1976","unstructured":"Guy W. The Clinical Global Impression Scale. In:  ECDEU Assessment Manual for Psychopharmacology-Revised. Rockville: US Dept. of Health, Education & Welfare, ADAMHA, NIMH Psychopharmacology Research Branch; 1976. p. 218\u201322."},{"key":"2626_CR15","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/1471-244X-11-83","volume":"11","author":"T Forkmann","year":"2011","unstructured":"Forkmann T, Scherer A, Boecker M, et al. The clinical global impression scale and the influence of patient or staff perspective on outcome. BMC Psychiatry. 2011;11:83. https:\/\/doi.org\/10.1186\/1471-244X-11-83.","journal-title":"BMC Psychiatry"},{"key":"2626_CR16","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.jval.2011.06.014","volume":"14","author":"DL Patrick","year":"2011","unstructured":"Patrick DL, Burke LB, Gwaltney CJ, et al. Content validity \u2013 establishing and reporting evidence in newly-developed patient reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 1 \u2013 eliciting concepts for a new PRO instrument. Value Health. 2011a;14:967\u201377.","journal-title":"Value Health"},{"issue":"8","key":"2626_CR17","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1007\/s11136-010-9677-6","volume":"19","author":"KE Lasch","year":"2010","unstructured":"Lasch KE, Marquis P, Vigneux M, Abetz L, Arnould B, Bayliss M, et al. PRO development: rigorous qualitative research as the crucial foundation. Qual Life Res. 2010;19(8):1087\u201396. https:\/\/doi.org\/10.1007\/s11136-010-9677-6 Epub 2010 May 30. PMID: 20512662; PMCID: PMC2940042. https:\/\/pubmed.ncbi.nlm.nih.gov\/20512662\/.","journal-title":"Qual Life Res"},{"issue":"7","key":"2626_CR18","first-page":"28","volume":"4","author":"J Busner","year":"2007","unstructured":"Busner J, Targum SD. The clinical global impressions scale: applying a research tool in clinical practice. Psychiatry (Edgmont). 2007;4(7):28\u201337. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC2880930\/.","journal-title":"Psychiatry (Edgmont)"},{"key":"2626_CR19","doi-asserted-by":"publisher","DOI":"10.4135\/9781412983655","volume-title":"Cognitive interviewing: a tool for improving questionnaire design","author":"GB Willis","year":"2005","unstructured":"Willis GB. Cognitive interviewing: a tool for improving questionnaire design. Thousand Oaks: Sage Publications; 2005."},{"issue":"19","key":"2626_CR20","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1212\/wnl.0000000000010634","volume":"95","author":"MS Robbins","year":"2020","unstructured":"Robbins MS, Victorio MC, Bailey M, Cook C, Garza I, Huff JS, et al. Quality improvement in neurology. Headache Quality Measurement Set. Neurology. 2020;95(19):866\u201373. https:\/\/doi.org\/10.1212\/wnl.0000000000010634.","journal-title":"Neurology"},{"key":"2626_CR21","unstructured":"FDA Guidance for Industry Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. 2009. https:\/\/www.fda.gov\/media\/77832\/download"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-022-02626-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-022-02626-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-022-02626-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T09:04:52Z","timestamp":1647594292000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-022-02626-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,18]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2626"],"URL":"https:\/\/doi.org\/10.1186\/s12883-022-02626-0","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,18]]},"assertion":[{"value":"24 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The interview guide and all processes and respondent-facing documents were approved by the New England IRB (#20200306) before research was initiated. All research and interview methodology was carried out in accordance with relevant guidelines and regulations.All patients and caregivers provided informed consent to participate. HCPs consent to participate through their contract agreements.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"D.C., M.N. and S.S. are employees of Amgen.J.C. and Michael Phinney are employees of IQVIA, which received professional service fees from Amgen Inc. for conducting this research.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"103"}}